KMC-RI reserved 20 beds for covid patients
Tired of too many ads? go ad free now
In the wake of the Covid cases resurfacing in parts of the state, and Covid deaths being reported, the health department decided to increase Covid testing. Ten centres were identified in the state for Covid testing, of which KMC-RI is also one.
Speaking to TOI, Dr Ishwar Hasabi, Superintendent of KMC-RI, said that currently 20 beds are arranged for Covid in the hospital. This will be increased as per the requirement. Special teams are formed, and no Covid case was found in any district under the jurisdiction of KMC-RI so far.
A meeting was already held with the chief medical officers of all the departments in the hospital. He said that even if there is a severe respiratory problem and symptoms of corona infection, one should get tested.
Testing for high-risk patients is ongoing. We have instructed everyone to wear masks and use hand sanitiser, said Hasabi.
Dr SF Kammar, Director, KMC-RI, said that they received guidelines from the govt to conduct tests for patients. Testing will be done at this hospital and will be extended to five districts, he informed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
3 hours ago
- The Hindu
US vaccination rates for measles, other diseases drop further, government data says
Vaccination rates for several diseases including measles, diphtheria and polio decreased among U.S. kindergartners in the 2024-25 school year from the year before, according to federal data posted on Thursday. The U.S. Centers for Disease Control and Prevention released the new figures at a time when the country faces a growing measles outbreak, with confirmed cases this month reaching the highest level since the disease was declared eliminated from the country in 2000. Secretary of Health and Human Services Robert F. Kennedy Jr. has long questioned the safety of vaccines, contrary to scientific evidence, and he has also suggested a link between vaccines and autism. The CDC data show vaccination rates have steadily trended down since the COVID-19 pandemic. For the measles, mumps and rubella vaccine, coverage went from 95.2% in the 2019-2020 school year to 92.7% last year, before landing at 92.5% in 2024-2025. In Texas, the epicenter of the recent outbreak, MMR coverage has fallen to 93.2% from 96.9% in 2019. Most people are protected from measles through herd immunity when more than 95% of people in the community are vaccinated, the CDC website says. An HHS spokesperson said the data released on Thursday showed a 'majority' of children continue to get routine childhood immunizations, and that vaccination remains the most effective way to protect children from measles and whooping cough. 'The decision to vaccinate is a personal one,' the spokesperson said. 'Parents should consult their healthcare providers on options for their families.' In addition, exemptions from one or more vaccines increased to 3.6% in 2024-2025 from 3.3% the year before, the CDC website said. Exemptions, which can be granted on medical or religious grounds, increased in 36 states and DC, with 17 states reporting exemptions exceeding 5 percent, it said.
NDTV
4 hours ago
- NDTV
US FDA Vaccine Chief Vinay Prasad Leaves Agency 3 Months After Appointment
Washington: The Food and Drug Administration's polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of biotech executives, patient groups and conservative allies of President Donald Trump. Dr. Vinay Prasad 'did not want to be a distraction' and was stepping down from his role as the FDA's top vaccine regulator 'to spend more time with his family,' a spokesperson for the Department of Health and Human Services said in a statement late Tuesday. Two people familiar with the situation told The Associated Press that Prasad was ousted following several recent controversies. They spoke on condition of anonymity to discuss internal personnel matters. Prasad did not immediately respond to requests for comment Wednesday morning. FDA's drug center director, Dr. George Tidmarsh, will take over Prasad's job in an acting role, according to an agency email shared with the AP. Tidmarsh started at the FDA last week after a decades-long career as a pharmaceutical executive and adjunct professor. Prasad joined the FDA in May from the University of California San Francisco, where he frequently criticized the FDA's approach to drug approvals and COVID-19 vaccines. His contrarian approach appeared to match that of his boss FDA Commissioner Marty Makary, who repeatedly praised Prasad's work and intellect. But in recent weeks Prasad became a target of right-wing activists, including Laura Loomer, who flagged Prasad's past statements criticizing Trump and praising liberal independent Senator Bernie Sanders. 'How did this Trump-hating Bernie Bro get into the Trump admin???' Loomer posted on X last week. Trump previously fired several national security officials a day after Loomer raised concerns about their loyalty. Prasad also attracted scrutiny for his handling of a recent safety issue surrounding the only approved gene therapy for Duchenne's muscular dystrophy. Under his direction, shipments of the therapy were briefly halted after a series of patient deaths, then resumed late Monday following vocal pushback from families of boys with the fatal muscle-wasting disorder. Prasad has long been skeptical of the therapy and other muscular dystrophy drugs sold by the drugmaker, Sarepta Therapeutics. As an academic, Prasad gained prominence by attacking the FDA for being too lenient in its standards for approving cancer drugs and other new therapies. That approach is at odds with Trump's Republican supporters, who generally favor speedier approvals and unfettered access to experimental treatments. During Trump's first term he signed the ' Right to Try ' law, a largely symbolic piece of legislation that won popular support from conservatives seeking to give terminal patients expanded access to unproven drugs. Prasad's decision to pause Sarepta's therapy was criticized last week by a columnist and the editorial board of The Wall Street Journal. Separately, Prasad's division issued three rejection letters this month to small biotech firms seeking approval for new gene therapies. Those drugs have been vigorously embraced by many of the anti-abortion groups in Trump's base for their potential to address intractable diseases that sometimes lead parents to terminate pregnancies. Prasad's predecessor in at FDA, Dr. Peter Marks, oversaw a dramatic rise in approvals for new gene therapies, which aim to treat or prevent disease by replacing or modifying a portion of patients' genetic code. Prasad has been an outspoken critic of Marks' leadership at FDA, which included overseeing the approval of the first COVID vaccines and therapies.
Time of India
5 hours ago
- Time of India
US vaccination rates for measles, other diseases drop further, government data says
London: Vaccination rates for several diseases including measles, diphtheria and polio decreased among U.S. kindergartners in the 2024-25 school year from the year before, according to federal data posted on Thursday. The U.S. Centers for Disease Control and Prevention released the new figures at a time when the country faces a growing measles outbreak , with confirmed cases this month reaching the highest level since the disease was declared eliminated from the country in 2000. Secretary of Health and Human Services Robert F. Kennedy Jr. has long questioned the safety of vaccines, contrary to scientific evidence, and he has also suggested a link between vaccines and autism. The CDC data show vaccination rates have steadily trended down since the COVID-19 pandemic. For the measles, mumps and rubella vaccine, coverage went from 95.2% in the 2019-2020 school year to 92.7% last year, before landing at 92.5% in 2024-2025. In Texas, the epicenter of the recent outbreak, MMR coverage has fallen to 93.2% from 96.9% in 2019. Most people are protected from measles through herd immunity when more than 95% of people in the community are vaccinated, the CDC website says. An HHS spokesperson said the data released on Thursday showed a "majority" of children continue to get routine childhood immunizations , and that vaccination remains the most effective way to protect children from measles and whooping cough. "The decision to vaccinate is a personal one," the spokesperson said. "Parents should consult their healthcare providers on options for their families." In addition, exemptions from one or more vaccines increased to 3.6% in 2024-2025 from 3.3% the year before, the CDC website said. Exemptions, which can be granted on medical or religious grounds, increased in 36 states and DC, with 17 states reporting exemptions exceeding 5 percent, it said. (Edited by Caroline Humer and David Gregorio)
